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Background: Endovascular treatment of the ascending aorta is particularly challenging because of the anatomic features of
this aortic segment. Only patients without connective tissue disorders, clinically relevant aortic regurgitation or stenosis,
or concomitant coronary artery disease can be considered for an endovascular procedure. We report our results in a series
of patients with aneurysms or intramural hematoma, penetrating ulcers, or floating thrombus who were scheduled for
stent grafting.
Methods: Only patients with ascending aortic pathology who were unfit for open surgery were treated with an endograft.
When preoperative computed tomography imaging showed severe calcification of the aortic arch or thrombus lining,
temporary clamping of the carotid arteries before wire and catheter introduction was performed. An extracorporeal
bypass from the right groin to both carotid arteries with a roller pump was established and maintained during the
procedure. The endograft was placed across the aortic valve into the left ventricle and deployed in a retrograde fashion.
At the end of the procedure, ventriculography and, if necessary, coronary angiography was performed to rule out any
damage to the left ventricle or the valve apparatus.
Result: Eleven patients were scheduled for stent graft exclusion of ascending aortic pathology. In five cases because of
discrepancies in length measurements and sizing, the thoracic endograft was cut to length intraoperatively after partial
deployment on the operating table and reloaded to avoid covering of the innominate artery. The mean length of the
ascending aorta covered was longer in aneurysm patients than in those with dissection. An 81-year-old patient presented
with a type Ia leak. The distal landing zone in one patient was enlarged by debranching. One patient died after wire
perforation of the left ventricle, and one patient sustained a cerebral stroke. Combined morbidity and mortality was 18%,
and the technical success rate was 91%.
Conclusions: Stent grafting of the ascending aorta is technically feasible but should be reserved for selected high-risk
patients only, preferably in centers where vascular specialists cooperate closely with interventional cardiologists. Cardiac
surgery with cardiopulmonary bypass is still the gold standard to treat ascending aortic aneurysms. Stent graft exclusion
of more advanced and complex ascending aortic pathology should be performed only in centers with the necessary















tThe incidence of thoracic aortic aneurysms is estimated
to be as high as 6 cases/100,000 person-years, and replace-
ment of the ascending aorta accounts for most thoracic
aortic procedures. Bicuspid and unicuspid aortic valves are
associated with ascending aortic aneurysms and dissections
and are still best treated by cardiac surgery, which permits
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doi:10.1016/j.jvs.2010.10.133reatment of the abnormal valve along with ascending
ortic replacement.
Endovascular management of aortic arch aneurysms is
outinely performed in many vascular centers. Aneurysms
nd dissections of the ascending aorta are still mainly
reated operatively with cardiopulmonary bypass: ascend-
ng aortic aneurysms with normal sinuses and aortic annu-
us require only replacement of the ascending aorta from
he sinotubular ridge to the origin of the innominate artery
ith a Dacron tube graft.
Owing to the significant morbidity and mortality of
hese procedures, high-risk patients are not considered for
ardiac surgery. A number of anecdotal reports have de-
cribed endovascular stent grafting of various pathologies,
ncluding deployment of a fenestrated stent graft to repair
n ascending aortic rupture.1-4 Endovascular treatment of
he ascending aorta is particularly challenging because of
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May 20111432 Kolvenbach et alchronic type A dissections can be treated with a tubular
endograft when the aortic valve and the coronary arteries
are not involved.5
An analysis in our clinic of 30 consecutive patients
admitted with ascending aortic pathology showed that the
ascending aneurysms in 75% had a conical shape without a
proximal landing zone. Only in a few cases did the ascend-
ing aorta have a tubular configuration with a long proximal
landing zone of at least 2 cm (Fig 1). This makes oversizing
and an optimal graft configuration particularly important.
Only patients without connective tissue disorders, clinically
relevant aortic incompetence, stenosis, or concomitant cor-
onary artery disease can be considered for an endovascular
procedure. We report our results in a series of patients with
aneurysms or various aortic pathologies who were sched-
uled for stent grafting.
METHODS
Only patients with ascending aortic pathology who
were considered unfit for open surgery were treated with an
endograft. Unfit or high risk was defined as an American
Society of Anesthesiologists (ASA) classification IV, age
70, a history of myocardial infarction, or renal insuffi-
ciency, severe chronic obstructive pulmonary disease
(COPD), compensated or prior heart failure, stroke, un-
controlled hypertension, or a combination of these factors.
A consensus conference was held before surgery with car-
diologists, anesthetists, and vascular surgeons. Cardiac sur-
geons were included in the decision-making process when
the cardiologist in charge wanted another surgical opinion.
The analysis excluded patients where the ascending
Fig 1. A, A tubular-shaped aneuaorta or zone 0 was the proximal landing zone for an aortic frch stent graft. Patients with acute type A dissections were
ot included because we did not have Internal Review
oard approval for endovascular treatment of these emer-
ency cases. Also excluded were patients with malperfusion
r any preoperative unstable clinical condition after type A
issection, and patients with severe aortic valvular disease,
ncluding aortic valvular incompetence as a consequence of
n acute type A dissection, coronary artery disease requiring
urgery, and any kind of connective tissue disorder.
Included were patients with intramural hematoma lo-
alized to the ascending aorta and complaining about chest
ain, floating thrombus after chronic type A dissection and
ultiple emboli, and penetrating aortic ulcers. Also in-
luded were aneurysm patients without aortic valve incom-
etence or significant dilatation of the aortic annulus re-
uiring composite graft replacement of the aortic valve and
he ascending aorta.
According to our protocol, patients with asymptomatic
enetrating aortic ulcers were initially managed conserva-
ively. Patients in whom symptoms developed that did not
esolve or who continued complaining about chest pain
ere classified as symptomatic, and endovascular exclusion
as discussed with the patient.5 Only aneurysm patients
ith an aortic diameter of6.0 cm were considered for an
ndograft.
All procedures were performed by the two senior
uthors (R.R.K. and R.K.). When preoperative com-
uted tomography (CT) imaging showed severe calcifi-
ation of the aortic arch or thrombus lining temporary,
lamping of the carotid arteries before wire and catheter
ntroduction was performed. An extracorporeal bypass
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Volume 53, Number 5 Kolvenbach et al 1433exchanger, membrane oxygenator, and a roller pump was
established and maintained during the procedure.6,7 Ace-
tylsalicylic acid (100 mg/d) was administered before the
procedure and continued indefinitely. All patients received
a 300-mg loading dose of clopidogrel, followed by 75 mg
daily for at least 6 to 12 months. During the intervention,
the patient received weight-adjusted intravenous heparin to
achieve an activated clotting time of 300 to 350 seconds for
the duration of the procedure.
Device success was defined as stable device placement
and adequate function as assessed by CT angiography scan
and echocardiography. Acute procedural success was de-
fined as device success with absence of periprocedural major
adverse cardiovascular and cerebral events 48 hours after
device implantation. Clinical adverse events were adjudi-
cated by an independent clinical events committee. Major
adverse cardiovascular and cerebral events consisted of
death from any cause, myocardial infarction (creatine kinase-
myocardial band more than twice the upper limit of nor-
mal), cardiac tamponade, stroke (as assessed by routine
neurologic assessment before and after procedure and be-
fore hospital discharge), emergent percutaneous coronary
intervention, cardiogenic shock, endocarditis, or aortic dis-
section. Major bleeding was defined as hemorrhage requir-
ing surgery or 3 units of blood transfusion.
The exact length of the graft required was determined
intraoperatively with a measuring catheter. Because of the
conical shape of the ascending aorta in aneurysm cases,
preoperative centerline measurement did not yield the in-
formation necessary for precise planning. The length of the
stent graft depended on the length of the outer curve of the
ascending aorta, which was regularly longer than the dis-
tance determined by centerline measurement (Table).
All operations were performed with the patient under
general anesthesia. In addition to our monitoring protocol
for thoracic endovascular aneurysm repair, transesophageal
ultrasound imaging was performed to control cardiac and
valvular function.
Cardiac arrest was induced with adenosine administra-
tion when required. A temporary ventricular pacemaker
was placed through the jugular vein. Accurate deployment
required lowering of the blood pressure 70 mm Hg to
avoid ballooning of the left ventricle when aortic regurgi-
tation was provoked after passage of the introducer sheath
into the left cardiac chamber. After road map angiography,
selective coronary angiography was performed to outline
the origin of the coronary arteries.
An ultrastiff guidewire (Lunderquist, Cook, Bjaevers-
kov, Denmark) was placed into the left ventricle after
passage of the aortic valve with a vertebral catheter over a
0.035-inch Terumo guidewire (Terumo Medical Corp,
Somerset, NJ). The endograft was carefully placed across
the aortic valve (Fig 2) until the nose cone of the endograft
was completely inside the left ventricle. This provoked
aortic regurgitation controlled by ultrasound imaging, and
the graft was deployed just distally to the coronary sinus,
trying to avoid kinking of the graft. dAfter full deployment, leaving the guidewire still in the
entricle, the sheath was removed. Contrast was injected to
heck the exact position of the endograft in relation to the
oronary sinus. The ultrastiff wire was exchanged for a
tandard 0.035-inch guidewire, and a pigtail catheter was
ositioned close to the coronary sinus. An injection of 30
L of contrast was given to rule out obstruction of the
oronary arteries. The kind of graft used depended on the
ize required.When a graft42mmwas necessary, we used
he Valiant device (Medtronic, Minneapolis, Minn); in
ther cases, the Cook ProForm graft was used.
Tracking of the stiff wire during the entire procedure
as essential to avoid ventricular perforation. At the end of
he procedure, ventriculography was performed to rule out
ny damage to the left ventricle or the valve apparatus. In
ase of any electrocardiogram (ECG) changes, coronary
ngiography was added before the catheter and sheaths
ere removed (Fig 2, C). Before discharge, contrast-
nhanced CT angiography and a cardiac ultrasound exam-
nation were performed.
All cases were approved by the Internal Review Board
fter presentation to a steering committee guided by car-
able. Patient’s characteristics and intraoperative data
ariablea
Patients (N  11)
Group Ib Group IIc
atients 7 (63.6) 4 (36.3)
ge, years 74 (69-82) 71 (67-84)
ender
Male 3 (27.2) 2 (18.1)
Female 4 (36.3) 2 (18.1)
hronic renal disease 2 (18.1) 0 (0)
ardiac diseased 5 (45.4) 4 (36.3)
revious cardiac valve surgerye 2 (18.1) 1 (9.0)
VD (previous TIA/CVA) 2 (18.1) 0 (0)
ypertension 6 (54.5) 4 (36.3)
iabetes 3 (27.2) 2 (18.1)
moking
Former smoker 2 (18.1) 1 (9)
Current smoker 5 (45.4) 3 (27.2)
Never smoked 0 0
ypercholesterolemia 4 (36.3) 2 (18.1)
revious aortic surgery 1 (9) 1 (9)
SA score 4.6 (4-5) 4.7 (4-5)
ortic diameter, mm 68.1 (60-79)
ength of aorta covered cm 10.09 (7-14) 8.75 (8-10)
ype I leak 1 (9) 0 (0)
ollow-up, months 9.1 (2-19) 12.5 (6-20)
troke 1 (9) 0
eath 1 (9) 0
SA, American Society of Anesthesiologists; CVA, cerebrovascular acci-
ent; CVD, cardiovascular disease; TIA, transient ischemic attack.
Categoric data are expressed as number (%); and continuous data are
resented as mean (range).
All aneurysm patients.
Patients with chronic uncomplicated type A dissection, intramural hema-
oma, floating thrombus, or penetrating aortic ulcer.
Includes previous myocardial infarction, coronary artery bypass grafting, or
ercutaneous angioplasty.
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May 20111434 Kolvenbach et almental character of the treatment, and other options, sur-
gical as well as conservative, were explained to them.
RESULTS
Between 2008 and June 2010, 11 patients were sched-
uled for stent graft exclusion of ascending aortic pathology.
The Table summarizes the indications for treatment in the
endovascular group. An iliac conduit to accommodate the
24F introducer sheath was required in one patient. In two
patients the right carotid artery was chosen as an access
vessel after cervical cut down without any neurologic se-
quelae. In five patients, because of discrepancies in length
measurements and sizing, the thoracic endograft was cut to
length intraoperatively after partial deployment on the op-
erating table and reloaded to avoid covering of the innom-
inate artery. The mean length of the ascending aorta cov-
ered was longer in aneurysm patients compared with
patients with various types of pathology (Table).
In all cases, the tip of the endograft was bent to get a
curved configuration after immersing the nose cone in cold
water. Because the graft was introduced into the left ven-
tricle, it had to adapt to the configuration of the left
Fig 2. A,Aortic regurgitation is shown after passage of t
is in the left ventricle. B, The endograft has been parti
deployment shows the bare springs are near the right co
Fig 3. A, The proximal landing zone in a conical-shape
with a valve-bearing conduit. B, A type I leak was still n
coiled through the innominate artery. D, Plain X-ray film
shows the stent graft and coils in the aneurysm sac.ventricle to avoid perforation. sOne type Ia leak was found in an 81-year-old patient.
hen the stiff guidewire was placed in the left ventricle, she
xperienced immediate aortic incompetence and ventricu-
ar tachycardia. The stent graft was placed too distally from
he sinotubular junction. The condition of the patient did
ot permit placement of a second short graft to seal the
eak. She was discharged after an uneventful recovery. After
follow-up of 12 months, she still had a type I leak but
efused any further treatment.
In patient 2, a type Ib leak was seen after stent graft
eployment. We decided to debranch the innominate ar-
ery with a cervical crossover bypass to enlarge the distal
anding zone and to deploy a distal extension. In addition,
sing the innominate artery as an access, coils were placed
irectly into the sac of the ascending aortic aneurysm, and
he origin of the innominate artery was occluded with an
mplatz (AGA Medical Corporation, Plymouth, Minn)
ccluder (Fig 3,A and B). A postoperative CT scan showed
omplete exclusion of the ascending aneurysm from blood
ow.
In one patient, the bare springs of the graft that was
eployed proximal to the sinotubular junction prevented
dograft through the aortic valve. The tip of the endograft
eployed. C, Control coronary angiography after stent
y artery.
nding aortic aneurysm is shown after aortic valve repair
after stent graft deployment. C, The aneurysm sac was
ws large-caliber coils near the endograft. E, Illustrationhe en
ally dd asce
oted
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Volume 53, Number 5 Kolvenbach et al 1435enced severe aortic incompetence combined with mitral
valve regurgitation due to the retrograde jet. A 42-mm
compliant balloon was used to pull back the stent graft. The
patient was discharged home with regular myocardial func-
tion and an aortic regurgitation fraction of 8%.
In two cases, a kink and compression of the stent graft
at the lesser ascending aortic curvature was seen due to the
disparity between the lengths of the outer curvature com-
pared with the inner curvature. This did not have any
hemodynamic consequences and did not have an effect on
aneurysm exclusion (Figs 4 and 5).
In two patients, the distal bare stents of the stent graft
Fig 4. A, A floating thrombus in ascending aorta. B, C
scan shows the exact placement of stent graft.C, A 3-dim
to the aortic valve and coronary sinus.
Fig 5. A, A computed tomography reconstruction sho
graft.were deployed at the level of the origin of the innominate frtery, and the bare springs protruded into the innomin-
te artery. A postoperative ECG-triggered and contrast-
nhanced control CT scans showed a completely stable
osition of the stent graft with no residual movement
uring cardiac cycle.
Combined mortality and morbidity was 18% (two pa-
ients). Ten patients were discharged to home or to a lesser
ependency unit. Two major complications occurred: One
atient who had recovered from two previous myocardial
nfarctions, died immediately after successful deployment
f the stent graft. The stiff guidewire had perforated the
all of the left ventricle. Emergency sternotomy was per-
al section of contrast-enhanced computed tomography
nal reconstruction shows the stent graft location is close
e stent graft. B, Illustration shows kinking of the stentoron
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May 20111436 Kolvenbach et alof multisystem organ failure 24 hours later. A second
patient sustained a massive stroke but was discharged to a
rehabilitation center. This event caused a change of our
protocol, as mentioned above. Two patients required pro-
longed ventilator support: Both had severe COPD and
were heavy smokers. They were discharged to home after
prolonged intensive care unit treatment.
DISCUSSION
Ascending aortic dilatation may be caused by intrinsic
pathology of the aortic wall or hemodynamic factors caused
by a stenotic aortic valve. High velocity and turbulent flow
downstream of the stenosis place mechanical stress on the
aortic wall (Fig 6).
The thin wall of the ascending aorta does not permit
aggressive over dilatation. The graft was deployed in most
cases without any additional balloon dilatation. The walls
of the aortic sinus of Valsalva are considerably thinner than
the wall of the aorta. Hooks or bare springs should there-
fore be deployed a safe distance from the sinus and the
origin of the coronary arteries to avoid erosion and perfo-
ration.
One of our first patients sustained a postoperative
stroke. Calcifications and thrombus lining of the ascending
aorta and aortic arch were the main parameters for in-
creased stroke risk. To avoid any further complications,
temporary clamping of the carotid arteries and extracorpo-
real bypass were performed. We considered an alternative
placement of filter wires but expected temporary clamping
and shunting to be safer although more invasive.7 This will
probably change in the near future. For catheter-based
aortic valve repair, transfemorally placed meshes covering
temporarily the inner surface of the aortic arch are under
clinical evaluation.
Access can be a problem, because a 24F access sheath
was required in most aneurysm cases. In two patients with
severe calcification of the iliac vessels, we had to use the left
Fig 6. A, A conical-shaped aneurysm. B, A 3-dcarotid artery as an access, which proved to be uneventful. elternatively, a small thoracotomy can be used to deploy
he endograft through the apex of the heart.
So far, no dedicated grafts have been developed for the
scending aorta. Because most aneurysms have conical
hape, a stent graft designed for type A dissection is not
ecessarily suitable for aneurysm repair. The anchoring
one of a few millimeters only requires fixation with
ooks, significant oversizing, and coil deployment into
he sac of the aneurysm if necessary. From our experi-
nce, a graft without bare springs is preferred to avoid
ompromising aortic valve closure. The tip or nose cone
f most commercially available grafts should be shorter
han the tips of the grafts designed for deployment in the
escending aorta.
The aortic impulse, which is directly proportional to
he mean blood pressure, the cross-sectional area of the
orta, and the duration during systole, varies inversely with
he distance from the aortic valve. In stent grafting of the
ortic arch and the descending aorta, high aortic impulses
an cause significant pulsate motion of the arch and inad-
ertent movement of the stent graft. In the future, more
ctive fixation with a stapler would probably permit safer
eployment, fewer type I leaks, and better long-term per-
ormance. Especially when treating more advanced stages
f aortic pathology, a valve-bearing conduit with fenestra-
ions for the coronary arteries will be necessary.
In most cases, a mismatch exists between the length of
he inner curvature of the ascending aorta and the outer
urvature, which can easily result in a kink of the graft.
nstead of using one graft, two or three stacked grafts only
cm in length could solve this problem.
To permit exact graft deployment and to prevent acci-
ental covering of the coronary arteries, temporary cardiac
rrest as well as rapid ventricular over pacing was used. Lee
t al8-10 have advocated partial right atrial inflow occlusion
or thoracic endovascular aneurysm repair to induce con-
rolled hypotension. In our patients, due to passage of the
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Volume 53, Number 5 Mastracci 1437gitation across the aortic valve. Yet, the retrograde ap-
proach can also cause temporary mitral valve insufficiency.
Intraoperative echocardiography shows a direct relation-
ship between blood pressure, duration of aortic insuffi-
ciency, and volume overload of the left ventricle. Partial
right atrial inflow occlusion could therefore be the safest
way to permit accurate graft deployment.
PROBLEMS AND TECHNICAL PITFALLS
This is only a small study with an inhomogeneous
group of patients. Several issues must be addressed before a
routine use can be advocated outside of studies. There
should be dedicated grafts for ascending aneurysms and for
acute dissections without bare springs. The problem of
cerebral emboli must be solved.11 Temporary cross clamp-
ing and cerebral perfusion with an extracorporeal pump is
relatively safe but further increases the invasiveness of the
procedure. We did not have any evidence of emboli in the
carotid arteries. Precise deployment of the graft adjacent to
the coronary arteries is essential in aneurysm patients. In
most cases, there is a landing zone of a fewmillimeters only,
deployment too distal from the sinotubular junction results
in kinking of the graft and a subsequent type I leak.
We do not have long-term follow-up data in these few
cases. A mean follow-up of 9 months only, although with-
out any changes in graft performance, is too short to permit
any conclusions about the long-term durability of this
technique. The hemodynamic consequences are unknown.
Theoretically, the elasticity of the ascending aorta should
decrease after graft deployment. It is unknownwhether this
affects blood pressure regulation, coronary artery perfu-
sion, or the stability of the endograft. Reduced aortic wall
elasticity can be associated with increased aortic regurgita-
tion and left ventricular hypertrophy.12 Ascending aortic
aneurysms already have reduced aortic wall elasticity asso-
ciated with various degrees of aortic regurgitation and
ventricular hypertrophy. We can only assume that deploy-
ment of a stent graft will not cause further deterioration of
cardiac function. One of the objectives of future studies
must be the measurement of the circumferential aortic
strain and deformation using cardiac gated image data.
CONCLUSIONS
Stent grafting of the ascending aorta is technically
feasible but should be reserved for selected high-risk pa-
tients only, preferably in centers where vascular specialists
cooperate closely with interventional cardiologists. Cardiac S





surgery with cardiopulmonary bypass and, if necessary,
eep hypothermia is still the gold standard when treating
scending aortic aneurysm, although still associated with
ignificant morbidity and mortality.13 Stent graft exclusion
f more advanced and complex ascending aortic aneurysms
hould be reserved for high-risk patients only in centers
ith the necessary skills to perform transvalvular cardiac
rocedures. This may change in the future when more
edicated grafts become available.
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Surgery, many say, is like riding a bike. Regardless of the
challenge of the terrain, the sophistication of the vehicle, or the
time passed since the cyclists’ last journey, basic principles prevail.
The advent of endovascular technology has given the field of
vascular surgery a lesson in self-directed learning and has taught use are, in many cases, experienced cyclists with constantly evolv-
ng bicycles.
With calculated steps over 20 years, a primitive endovascular
raft for an infrarenal aneurysm1 has evolved into branched and
enestrated technology to treat thoracoabdominal disease, while
taying true to surgical principles. The natural progression of this
